TAK 21d |
Catalog No.GC16033 |
TAK 21d(화합물 21d)는 강력한 경구 활성이며 hFAAH, rFAAH에 대해 각각 IC50이 0.72, 0.28nM인 혈뇌장벽 교차혈액뇌장벽 지방산 아미드 가수분해효소(FAAH) 억제제입니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1143578-94-2
Sample solution is provided at 25 µL, 10mM.
GlpBio Products Cited In Reputable Papers
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cas No. | 1143578-94-2 | SDF | |
Chemical Name | 4-(4-(3,4-difluorophenyl)pyrimidin-2-yl)-N-(pyridazin-3-yl)piperazine-1-carboxamide | ||
Canonical SMILES | FC1=CC=C(C2=NC(N3CCN(C(NC4=CC=CN=N4)=O)CC3)=NC=C2)C=C1F | ||
Formula | C19H17F2N7O | M.Wt | 397.38 |
Solubility | <7.95mg/ml in 1eq. HCl | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Complete Stock Solution Preparation Table
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.5165 mL | 12.5824 mL | 25.1648 mL |
5 mM | 0.5033 mL | 2.5165 mL | 5.033 mL |
10 mM | 0.2516 mL | 1.2582 mL | 2.5165 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC60410 (Rac)-3′-Hydroxy simvastatin
- GC40960 20α-dihydro Prednisolone
- GC39408 Neticonazole
- GC35713 CLP290
- GC46224 S-Phenylcysteine
- GC44615 PGP-4008
- GC17820 AS8351
- GC40577 11β-13,14-dihydro-15-keto Prostaglandin F2α
- GC14493 4μ8C
- GC18027 Huwentoxin XVI
- GC15696 Sorbitol
- GC32641 Rafigrelide (3,3-Dimethylanagrelide)
- GC34342 BAY885
- GC42908 BB-22 7-hydroxyquinoline isomer
- GC15160 TC 2559 difumarate
- GC16031 1-(3-Chlorophenyl)piperazine (hydrochloride)
- GC31749 Columbin
리뷰
Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *